Clin2
NCT07755150Possibly a fitNot yet recruiting

Study of an experimental pill for type 2 diabetes

Type 2 Diabetes Mellitus

Part of Hormones & metabolism clinical trials.

This trial tests an experimental pill called DA-302168S to see if it helps lower blood sugar in people with type 2 diabetes. It is for patients who are already managing their diabetes with metformin or lifestyle changes, and it focuses on safety and effectiveness over about 6 months.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
272 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old.
  • You have had type 2 diabetes for at least 3 months.
  • You are either on a stable dose of metformin (a common diabetes pill) for at least 8 weeks, or you control your blood sugar with diet and exercise only.
  • Your most recent HbA1c (a blood test that measures average blood sugar) is between 7.5% and 11%.
  • Your body mass index (BMI) is between 22.5 and 40, and your weight has been stable for the past 3 months.
  • You do not have other types of diabetes, serious diabetes complications, or uncontrolled thyroid or heart conditions.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07527650Recruiting· Phase 2
Testing HM15275 for Type 2 Diabetes Management

This study tests a new medication called HM15275 to help control blood sugar in people with type 2 diabetes. The trial will check if the medication works well and is safe when added to diet, exercise, or metformin treatment.

Mesa, Arizona
NCT07662109Recruiting· Phase 3
Testing a new combo pill for type 2 diabetes

This study tests if a new medicine (elecoglipron) combined with dapagliflozin is safe and works better for adults with type 2 diabetes that isn't well controlled by diet or other medications.

Huntsville, Alabama
NCT07193459Recruiting· Phase 3
Study of an oral tablet for type 2 diabetes

This trial tests an experimental daily tablet for adults with type 2 diabetes who are not currently on any diabetes medication. It aims to see if the tablet can safely lower blood sugar levels over time.

Beijing, Beijing Municipality
NCT07394114Recruiting· Phase 3
Study of a new medicine for type 2 diabetes not controlled by diet and exercise

This trial tests a new medicine called HDM1005 for people with type 2 diabetes who haven't been helped enough by diet and exercise alone, and who haven't taken any diabetes medication in the last 12 weeks. It aims to see if the medicine can help lower blood sugar levels safely.

Beijing
NCT07801820Recruiting· Phase 2
Oral diabetes medication study

This study tests an investigational pill for people with type 2 diabetes whose blood sugar is not well controlled despite lifestyle changes or metformin. The pill may help improve blood sugar control and is taken by mouth.

Beijing, Beijing Municipality
NCT07599410Recruiting· Phase 2
Testing HRS9531 for Type 2 Diabetes Blood Sugar Control

This study tests whether a new tablet called HRS9531 helps people with type 2 diabetes control their blood sugar better. You would take it along with your current diabetes management (lifestyle changes or metformin) over several months.

Beijing, Beijing Municipality

Hear when a new Type 2 Diabetes Mellitus trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.